IMAC (IMAC) Competitors $0.05 +0.00 (+0.22%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock IMAC vs. SXTP, ADIL, NCNA, SILO, SINT, CPHI, CANF, MBIO, ONCO, and MNDRShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include 60 Degrees Pharmaceuticals (SXTP), Adial Pharmaceuticals (ADIL), NuCana (NCNA), Silo Pharma (SILO), Sintx Technologies (SINT), China Pharma (CPHI), Can-Fite BioPharma (CANF), Mustang Bio (MBIO), Onconetix (ONCO), and Mobile-health Network Solutions (MNDR). These companies are all part of the "medical" sector. IMAC vs. 60 Degrees Pharmaceuticals Adial Pharmaceuticals NuCana Silo Pharma Sintx Technologies China Pharma Can-Fite BioPharma Mustang Bio Onconetix Mobile-health Network Solutions 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and IMAC (NASDAQ:IMAC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment. Does the MarketBeat Community believe in SXTP or IMAC? IMAC received 70 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 60.17% of users gave IMAC an outperform vote while only 5.26% of users gave 60 Degrees Pharmaceuticals an outperform vote. CompanyUnderperformOutperform60 Degrees PharmaceuticalsOutperform Votes15.26%Underperform Votes1894.74% IMACOutperform Votes7160.17% Underperform Votes4739.83% Which has higher earnings and valuation, SXTP or IMAC? 60 Degrees Pharmaceuticals has higher earnings, but lower revenue than IMAC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$607.57K7.66-$3.77M-$50.41-0.06IMAC$15.22M0.08-$10.54MN/AN/A Do analysts prefer SXTP or IMAC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer SXTP or IMAC? In the previous week, IMAC had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for IMAC and 1 mentions for 60 Degrees Pharmaceuticals. IMAC's average media sentiment score of 0.64 beat 60 Degrees Pharmaceuticals' score of 0.47 indicating that IMAC is being referred to more favorably in the news media. Company Overall Sentiment 60 Degrees Pharmaceuticals Neutral IMAC Positive Do insiders & institutionals have more ownership in SXTP or IMAC? 8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. Comparatively, 24.3% of IMAC shares are owned by institutional investors. 10.3% of 60 Degrees Pharmaceuticals shares are owned by company insiders. Comparatively, 10.0% of IMAC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is SXTP or IMAC more profitable? 60 Degrees Pharmaceuticals has a net margin of 0.00% compared to IMAC's net margin of -75.40%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat IMAC's return on equity.Company Net Margins Return on Equity Return on Assets 60 Degrees PharmaceuticalsN/A N/A -113.43% IMAC -75.40%-52.17%-34.51% Which has more volatility and risk, SXTP or IMAC? 60 Degrees Pharmaceuticals has a beta of 3.41, indicating that its share price is 241% more volatile than the S&P 500. Comparatively, IMAC has a beta of -0.88, indicating that its share price is 188% less volatile than the S&P 500. Summary60 Degrees Pharmaceuticals and IMAC tied by winning 7 of the 14 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMAC vs. The Competition Export to ExcelMetricIMACSpecialty Outpatient Clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20M$1.00M$5.31B$7.35BDividend YieldN/AN/A5.12%4.30%P/E RatioN/AN/A21.8617.80Price / Sales0.080.08380.5497.75Price / CashN/AN/A38.2634.64Price / Book0.070.076.453.98Net Income-$10.54M-$10.54M$3.22B$247.81M7 Day PerformanceN/AN/A2.85%1.80%1 Month PerformanceN/AN/A-8.67%-6.97%1 Year PerformanceN/AN/A11.46%1.30% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMACIMACN/A$0.05+0.2%N/A-98.7%$1.20M$15.22M0.00106SXTP60 Degrees Pharmaceuticals1.0545 of 5 stars$3.26+10.1%N/A+151.0%$4.80M$607,574.00-0.323Short Interest ↓ADILAdial Pharmaceuticals2.3556 of 5 stars$0.72+2.1%$8.00+1,003.8%-70.4%$4.77MN/A-0.2220Positive NewsNCNANuCana2.6625 of 5 stars$0.83+10.6%$25.00+2,913.5%-78.3%$4.71MN/A-0.0830Positive NewsSILOSilo Pharma0.9227 of 5 stars$1.04-1.9%N/A-45.2%$4.66M$72,102.00-0.852Short Interest ↓Positive NewsGap UpSINTSintx Technologies0.2279 of 5 stars$1.85-2.6%N/A-76.5%$4.65M$1.25M-0.0440Short Interest ↑CPHIChina PharmaN/A$0.14-0.8%N/A-95.5%$4.61M$4.53M0.00250Analyst ForecastCANFCan-Fite BioPharma2.1634 of 5 stars$1.30-17.2%$14.00+976.9%-38.8%$4.60M$667,000.00-0.738Analyst ForecastNews CoverageGap UpHigh Trading VolumeMBIOMustang Bio1.7203 of 5 stars$1.36-2.2%$100.00+7,252.9%-93.1%$4.50MN/A-0.02100Short Interest ↑ONCOOnconetix0.9459 of 5 stars$0.07+11.7%N/A-98.8%$4.49M$1.87M0.0012Short Interest ↓MNDRMobile-health Network SolutionsN/A$1.55+0.6%N/A-99.0%$4.48M$13.97M0.00N/AShort Interest ↑Negative NewsGap Down Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals Competitors Adial Pharmaceuticals Competitors NuCana Competitors Silo Pharma Competitors Sintx Technologies Competitors China Pharma Competitors Can-Fite BioPharma Competitors Mustang Bio Competitors Onconetix Competitors Mobile-health Network Solutions Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMAC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMAC Stock Free IMAC Stock Alerts